Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update 

Go back to Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update 
(NASDAQ: CMPX) Delayed: 2.10 +0.08 (3.96%)
Previous Close $2.02    52 Week High
Open $2.04    52 Week Low
Day High $2.10    P/E N/A 
Day Low $2.02    EPS
Volume 3,389,778